WeVote
Log In

Bill

Bill

HB 29

Sale and Purchase of Ivermectin

2026 Regular Session Introduced by Webster Barnaby and 4 co-sponsors

Florida bill HB 29 would modify ivermectin sale and purchase regulations, but was withdrawn before introduction; exact provisions and impacts remain undisclosed.

Withdrawn prior to introduction
#publichealth
0
WeVote Research Nonpartisan
Bill Summary · HB 29

Legislative bill overview

HB 29 proposes to modify Florida's regulatory framework governing the sale and purchase of ivermectin, a medication primarily used to treat parasitic infections in humans and animals. The bill was referred to relevant health and professional regulatory subcommittees but was withdrawn prior to formal introduction, so its specific provisions remain unclear from public records.

Why is this important

Ivermectin has been at the center of significant public health debate, particularly following claims of its effectiveness against COVID-19 that were not supported by clinical evidence. Any legislative changes to its availability could affect prescription requirements, veterinary oversight, or accessibility—with implications for both legitimate medical use and potential misuse.

Potential points of contention

  • Regulatory oversight vs. access: Whether changes would loosen prescribing requirements or veterinary supervision, raising concerns about appropriate medical gatekeeping versus patient autonomy
  • Public health messaging: Legislation on ivermectin availability occurs amid ongoing controversy about its off-label promotion, creating risks of misinterpretation regarding its actual clinical uses
  • Interstate supply concerns: Florida regulatory changes could affect broader patterns of medication sourcing, particularly if the bill addresses acquisition without prescription

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.